Skip to main content

Semax vs DSIP

Both Semax and DSIP are used for neuroprotection. Here's how their evidence, dosing, and regulatory status actually compare.

Semax

Evidence B

Semax (MEHFPGP)

A synthetic ACTH fragment that increases BDNF levels and enhances focus, memory, and mental clarity. Delivered intranasally for rapid cognitive effects.

View full Semax profile →

DSIP

Evidence C

Delta Sleep-Inducing Peptide

A nonapeptide originally isolated from rabbit blood after EEG-defined slow-wave sleep induction. Inconsistent human evidence for sleep but explored for stress and analgesia.

View full DSIP profile →

Side-by-Side

AttributeSemaxDSIP
Evidence GradeBC
FDA StatusNot FDA-approved in US — approved in Russia for stroke and cognitive disordersNot FDA-approved — research compound
Typical Dose200–600 mcg intranasal, morning100–300 mcg before bed (subcutaneous)
Clinics Indexed8938
Categoriescognitive, neuroprotectionsleep, neuroprotection

Key reported benefits — Semax

  • BDNF increase
  • Enhanced focus
  • Memory improvement
  • Neuroprotection

Key reported benefits — DSIP

  • Slow-wave-sleep signals (preclinical)
  • Stress/cortisol modulation
  • Possible analgesic effect

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons